Evaluation of community health screening participants' knowledge of cardiovascular risk factors

Journal of the American Pharmacists Association

Volumn 49, Issue 4, 2009, Pages 529-537

  Mooney, Leslie A ^a   Franks, Amy M ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Cardiometabolic risk; Health screening; Patient education; Questionnaire; Risk factors

Indexed keywords

ADULT; AGED; ARTICLE; ATTITUDE TO HEALTH; CARDIOVASCULAR DISEASE; COMMUNITY CARE; COMPARATIVE STUDY; CROSS-SECTIONAL STUDY; EVALUATION; FEMALE; HUMAN; MALE; MASS SCREENING; MIDDLE AGED; PATIENT EDUCATION; PILOT STUDY; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; UNITED STATES;

ADULT; AGED; AGED, 80 AND OVER; ARKANSAS; CARDIOVASCULAR DISEASES; COMMUNITY HEALTH SERVICES; CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MASS SCREENING; MIDDLE AGED; PATIENT EDUCATION AS TOPIC; PILOT PROJECTS; QUESTIONNAIRES; RISK ASSESSMENT; RISK FACTORS; YOUNG ADULT;

EID: 67651012034     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/JAPhA.2009.08120     Document Type: Article

References (31)

1. Rosamond W, Flegal K, Furie K, et al. Heart disease and stroke statistics: 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2008;117:e25-46.
2. Jafari M, Masih M, Emerson JF. The value of pharmacist involvement in a point-of-care service, walk-in lipid screening program. Pharmacotherapy. 2001;21:1403-6.
3. Liu Y, Mentele LJ, McDonough RP, et al. Community pharmacist assessment of 10-year risk of coronary heart disease for union workers and their dependents. J Am Pharm Assoc. 2008;48:515-7.
4. Madejski RM, Madejski TJ. Cholesterol screening in a community pharmacy. J Am Pharm Assoc. 1996;36:243-8.
5. Mangum SA, Kraenow KR, Narducci WA. Identifying at-risk patients through community pharmacy-based hypertension and stroke prevention screening projects. J Am Pharm Assoc. 2003;43:50-5.
6. Snella KA, Canales AE, Irons BK, et al. Pharmacy- and community-based screenings for diabetes and cardiovascular conditions in high-risk individuals. J Am Pharm Assoc. 2006;46:370-7 [correction: J Am Pharm Assoc. 2006;46:666-7].
7. Ali F, Laurin MY, Lariviere C, et al. The effect of pharmacist intervention and patient education on lipid-lowering medication compliance and plasma cholesterol levels. Can J Clin Pharmacol. 2003;10:101-6.
8. Clifford RM, Davis WA, Batty KT, Davis TME. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care. 2005;28:771-6.
9. Cranor CW, Christensen DB. The Asheville Project: short-term outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:149-59.
10. Cranor CW, Bunting BA, Christensen DB. The Asheville Project: long-term clinical and economic outcomes of a community pharmacy diabetes care program. J Am Pharm Assoc. 2003;43:173-84.
11. Guirguis LM, Johnson JA. Diabetes: are pharmacists making an impact on patient outcomes? Can Pharm J. 2003;136:24-8.
12. Kiel PJ, McCord AD. Pharmacist impact on clinical outcomes in a diabetes disease management program via collaborative practice. Ann Pharmacother. 2005;39:1828-32.
13. Lee SSC, Cheung PYP, Chow MSS. Benefits of individualized counseling by the pharmacist on the treatment outcomes of hyperlipidemia in Hong Kong. J Clin Pharmacol. 2004;44:632-9.
14. McCord AD. Clinical impact of a pharmacist-managed diabetes mellitus drug therapy management service. Pharmacotherapy. 2006;26:248-53.
15. Paulos CP, Nygren CEA, Celedon C, Carcamo CA. Impact of a pharmaceutical care program in a community pharmacy on patients with dyslipidemia. Ann Pharmacother. 2005;39:939-43.
16. Ragucci KR, Fermo JD, Wessell AM, Chumney EC. Effectiveness of pharmacist-administered diabetes mellitus education and management services. Pharmacotherapy. 2005;25:1809-16.
17. Shibley MC, Pugh CB. Implementation of pharmaceutical care services for patients with hyperlipidemias by independent community pharmacy practitioners. Ann Pharmacother. 1997;31:713-9.
18. Simpson SH, Johnson JA, Biggs RS, Tsuyuki RT. Greater effect of enhanced pharmacist care on cholesterol management in patients with diabetes mellitus: a planned subgroup analysis of the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Pharmacotherapy. 2004;24:389-94.
19. Dracup K, McKinley S, Doering LV, et al. Acute coronary syndrome: what do patients know? Arch Intern Med. 2008;168:1049-54.
20. Kirkland SA, MacLean DR, Langille DB, et al. Knowledge and awareness of risk factors for cardiovascular disease among Canadians 55 to 74 years of age: results from the Canadian Heart Health Surveys, 1986-1992. CMAJ. 1999;161:s10-6.
21. Potvin L, Richard L, Edwards AC. Knowledge of cardiovascular disease risk factors among the Canadian population: relationships with indicators of socioeconomic status. CMAJ. 2000;162:s5-11.
22. Wagner J, Lacey K, Abbott G, et al. Knowledge of heart disease risk in a multicultural community sample of people with diabetes. Ann Behav Med. 2006;31:224-30.
23. Rothman AJ, Kiviniemi MT. Treating people with information: an analysis and review of approaches to communicating health risk information. J Natl Cancer Inst Monogr. 1999;1999:44-51.
24. Guirguis LM, Kieser MA, Chewning BA, Kanous NL. Recall of A1C, blood pressure, and cholesterol levels among community pharmacy patients with diabetes. J Am Pharm Assoc. 2003;47:29-34.
25. Alm-Roijer C, Fridlund B, Stagmo M, Erhardt L. Knowing your risk factors for coronary heart disease improves adherence to advice on lifestyle changes and medication. J Cardiovasc Nurs. 2006;21:e24-31.
26. Centers for Disease Control and Prevention. Behavioral Risk Factor Surveillance System (BRFSS) questionnaires. Accessed at www.cdc.gov/brfss/ questionnaires/english.htm, May 7, 2007.
27. Centers for Disease Control and Prevention. National Health and Nutrition Examination Survey (NHANES) survey questionnaires, examination components and laboratory components, 2005-2006. Accessed at www.cdc.gov/nchs/about/major/ nhanes/nhanes2005-2006/questexam05-06.htm, May 7, 2007.
28. Mokdad AH, Bowman BA, Ford ES, et al. The continuing epidemics of obesity and diabetes in the United States. JAMA. 2001;286:1195-1200.
29. American Diabetes Association, American College of Cardiology. The diabetes-heart disease link: surveying attitudes, knowledge and risk: executive summary. Accessed at www.diabetes.org/uedocuments/executivesummary.pdf, August 26, 2008.
30. Christian AH, Rosamond W, White AR, Mosca L. Nine-year trends and racial and ethnic disparities in women's awareness of heart disease and stroke: an American Heart Association national study. J Womens Health. 2007;16:68-81.
31. Williams A, Lindsell C, Rue L, Blomkalns A. Emergency department education improves patient knowledge of coronary artery disease risk factors but not the accuracy of their own risk perception. Prev Med. 2007;44:520-5.